{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:56:13Z","timestamp":1790744173903,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rhabdomyosarcoma (RMS) is a prevalent soft tissue sarcoma in pediatric populations characterized by dysregulated myogenesis and limited treatment options. Notably, fusion negative RMS (FN-RMS) constitutes the predominant subtype in pediatric patients and commonly harbors RAS mutations, resulting in uncontrolled cell proliferation and invasion. To date, the precise molecular determinants underlying FN-RMS tumor biology remain poorly understood, but there is increasing evidence implicating aberrant cytoskeletal remodeling in promoting malignant phenotypes. In this study, we present MICAL2, a flavin monooxygenase involved in regulating actin dynamics, as a novel driver of FN-RMS tumor progression. We first revealed elevated MICAL2 expression in FN-RMS cell lines, which was consistent with prior reports in other malignancies, then demonstrated that its silencing altered tumor cell behaviors. By knocking down MICAL2 using RNA interference strategies, murine and human FN-RMS cells displayed reduced proliferative and migratory capacities in vitro, which translated to attenuated primary tumor growth, inhibited metastasis formation, and improved functional performances in vivo. Furthermore, multi-omics analyses highlighted the molecular changes associated with MICAL2 silencing, including simultaneous suppression of oncogenic programs and enhancement of muscle integrity and oxidative metabolic function. Collectively, these data highlight the duality of MICAL2 as a cytoskeletal regulator whose dysregulation may disrupt myogenic identity and promote FN-RMS pathogenesis.<\/jats:p>","DOI":"10.1038\/s41419-026-09029-w","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:25:44Z","timestamp":1783430744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the dual roles of MICAL2 in skeletal muscle physiology and fusion negative rhabdomyosarcoma tumor progression"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2592-1591","authenticated-orcid":false,"given":"Ashley","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nefele","family":"Giarratana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simen","family":"Cassiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7477-1638","authenticated-orcid":false,"given":"Martina","family":"Biglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Rinvenuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Yedigaryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Pozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro Cortes","family":"Calabuig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-8752","authenticated-orcid":false,"given":"Pedro","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongpeng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margalida I.","family":"Campaner Socias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1296-2570","authenticated-orcid":false,"given":"Jianhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fanzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0191-3904","authenticated-orcid":false,"given":"Rik","family":"Gijsbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2422-3757","authenticated-orcid":false,"given":"Maurilio","family":"Sampaolesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"9029_CR1","doi-asserted-by":"publisher","unstructured":"Relaix F, Bencze M, Borok MJ, Der Vartanian A, Gattazzo F, Mademtzoglou D et al. Perspectives on skeletal muscle stem cells. Nat Commun. 2021;12. https:\/\/doi.org\/10.1038\/s41467-020-20760-6.","DOI":"10.1038\/s41467-020-20760-6"},{"key":"9029_CR2","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3390\/ijms21051830","volume":"21","author":"H Yamakawa","year":"2020","unstructured":"Yamakawa H, Kusumoto D, Hashimoto H, Yuasa S. Stem Cell Aging in Skeletal Muscle Regeneration and Disease. Int J Mol Sci. 2020;21:1830.","journal-title":"Int J Mol Sci"},{"key":"9029_CR3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/j.2040-4603.2015.tb00646.x","volume":"5","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Bentzinger CF, Sincennes MC, Rudnicki MA. Satellite cells and skeletal muscle regeneration. Compr Physiol. 2015;5:1027\u201359.","journal-title":"Compr Physiol"},{"key":"9029_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10974-019-09511-3","volume":"40","author":"B Chen","year":"2019","unstructured":"Chen B, Shan T. The role of satellite and other functional cell types in muscle repair and regeneration. J Muscle Res Cell Motil. 2019;40:1\u20138.","journal-title":"J Muscle Res Cell Motil"},{"key":"9029_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3961","volume":"15","author":"VP Kashi","year":"2015","unstructured":"Kashi VP, Hatley ME, Galindo RL. Probing for a deeper understanding of rhabdomyosarcoma: Insights from complementary model systems. Nat Rev Cancer. 2015;15:426\u201339.","journal-title":"Nat Rev Cancer"},{"key":"9029_CR6","doi-asserted-by":"publisher","unstructured":"Gustafson AL, Durbin AD, Artinger KB, Ford HL. Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcoma. Front Cell Dev Biol. 2025; 12. https:\/\/doi.org\/10.3389\/fcell.2024.1521523.","DOI":"10.3389\/fcell.2024.1521523"},{"key":"9029_CR7","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.3390\/cancers15215269","volume":"15","author":"A Zarrabi","year":"2023","unstructured":"Zarrabi A, Perrin D, Kavoosi M, Sommer M, Sezen S, Mehrbod P, et al. Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies. Cancers. 2023;15:5269.","journal-title":"Cancers"},{"key":"9029_CR8","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.1002\/cam4.2504","volume":"8","author":"E Hibbitts","year":"2019","unstructured":"Hibbitts E, Chi Y-Y, Hawkins DS, Barr FG, Bradley JA, Dasgupta R, et al. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the Children\u2019s Oncology Group. Cancer Med. 2019;8:6437\u201348.","journal-title":"Cancer Med"},{"key":"9029_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.humpath.2023.12.004","volume":"147","author":"CA Dehner","year":"2024","unstructured":"Dehner CA, Rudzinski ER, Davis JL. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry. Hum Pathol. 2024;147:72\u201381.","journal-title":"Hum Pathol"},{"key":"9029_CR10","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/genes12101500","volume":"12","author":"CA Dehner","year":"2021","unstructured":"Dehner CA, Armstrong AE, Yohe M, Shern JF, Hirbe AC. Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma. Genes. 2021;12:1500.","journal-title":"Genes"},{"key":"9029_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1158\/2159-8290.CD-13-0639","volume":"4","author":"JF Shern","year":"2014","unstructured":"Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, Rosenberg M, et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov. 2014;4:216\u201331.","journal-title":"Cancer Discov"},{"key":"9029_CR12","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1200\/JCO.20.03060","volume":"39","author":"JF Shern","year":"2021","unstructured":"Shern JF, Selfe J, Izquierdo E, Patidar R, Chou H-C, Song YK, et al. Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium. J Clin Oncol. 2021;39:2859\u201371.","journal-title":"J Clin Oncol"},{"key":"9029_CR13","doi-asserted-by":"crossref","unstructured":"Lim S, Woo S, Lee KW, Kim KD. Roles of cytoskeleton in metastasis: from its mechanism to therapeutic strategies. Exp Mol Med. 2026;1\u201313.","DOI":"10.1038\/s12276-025-01608-9"},{"key":"9029_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8:455.","journal-title":"Signal Transduct Target Ther"},{"key":"9029_CR15","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1007\/s11033-022-08025-5","volume":"50","author":"M Li","year":"2023","unstructured":"Li M, Peng L, Wang Z, Liu L, Cao M, Cui J, et al. Roles of the cytoskeleton in human diseases. Mol Biol Rep. 2023;50:2847\u201356.","journal-title":"Mol Biol Rep"},{"key":"9029_CR16","doi-asserted-by":"publisher","first-page":"618261","DOI":"10.3389\/fcell.2020.618261","volume":"8","author":"E Balta","year":"2021","unstructured":"Balta E, Kramer J, Samstag Y. Redox Regulation of the actin cytoskeleton in cell migration and adhesion: on the way to a spatiotemporal view. Front Cell Dev Biol. 2021;8:618261.","journal-title":"Front Cell Dev Biol"},{"key":"9029_CR17","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1242\/jcs.202028","volume":"130","author":"S Fr\u00e9mont","year":"2017","unstructured":"Fr\u00e9mont S, Romet-Lemonne G, Houdusse A, Echard A. Emerging roles of MICAL family proteins - from actin oxidation to membrane trafficking during cytokinesis. J Cell Sci. 2017;130:1509\u201317.","journal-title":"J Cell Sci"},{"key":"9029_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2013.12.035","volume":"156","author":"MR Lundquist","year":"2014","unstructured":"Lundquist MR, Storaska AJ, Liu TC, Larsen SD, Evans T, Neubig RR, et al. Redox Modification of Nuclear Actin by MICAL-2 Regulates SRF Signaling. Cell. 2014;156:563\u201376.","journal-title":"Cell"},{"key":"9029_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12964-022-00952-x","volume":"20","author":"Q Wang","year":"2022","unstructured":"Wang Q, Qi C, Min P, Wang Y, Ye F, Xia T, et al. MICAL2 contributes to gastric cancer cell migration via Cdc42-dependent activation of E-cadherin\/\u03b2-catenin signaling pathway. Cell Commun Signal CCS. 2022;20:136.","journal-title":"Cell Commun Signal CCS"},{"key":"9029_CR20","doi-asserted-by":"publisher","unstructured":"Wang Y, Deng W, Zhang Y, Sun S, Zhao S, Chen Y, et al. MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR\/P38 signalling activation. Acta Physiol Oxf Engl. 2018; 222. https:\/\/doi.org\/10.1111\/APHA.12920.","DOI":"10.1111\/APHA.12920"},{"key":"9029_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52729-6","volume":"14","author":"Z Liu","year":"2024","unstructured":"Liu Z, Sun B, Xu A, Tang J, Zhang H, Gao J, et al. MICAL2 implies immunosuppressive features and acts as an independent and adverse prognostic biomarker in pancreatic cancer. Sci Rep. 2024;14:3177.","journal-title":"Sci Rep"},{"key":"9029_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2020.04.019","volume":"483","author":"W Zhou","year":"2020","unstructured":"Zhou W, Liu Y, Gao Y, Cheng Y, Chang R, Li X, et al. MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma. Cancer Lett. 2020;483:75\u201386.","journal-title":"Cancer Lett"},{"key":"9029_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02886-z","volume":"11","author":"N Giarratana","year":"2020","unstructured":"Giarratana N, Conti F, La Rovere R, Gijsbers R, Carai P, Duelen R, et al. MICAL2 is essential for myogenic lineage commitment. Cell Death Dis. 2020;11:654.","journal-title":"Cell Death Dis"},{"key":"9029_CR24","doi-asserted-by":"publisher","first-page":"dmm049004","DOI":"10.1242\/dmm.049004","volume":"15","author":"K Nakahata","year":"2022","unstructured":"Nakahata K, Simons BW, Pozzo E, Shuck R, Kurenbekova L, Prudowsky Z, et al. K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications. Dis Model Mech. 2022;15:dmm049004.","journal-title":"Dis Model Mech"},{"key":"9029_CR25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/pbc.23048","volume":"57","author":"JL Meadors","year":"2011","unstructured":"Meadors JL, Cui Y, Chen Q-R, Song YK, Khan J, Merlino G, et al. Murine Rhabdomyosarcoma Is Immunogenic and Responsive to T-Cell-Based Immunotherapy. Pediatr Blood Cancer. 2011;57:921\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"9029_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13577-025-01212-z","volume":"38","author":"R Wang","year":"2025","unstructured":"Wang R, Hou Z, Gao X, Wu B, Hu H, Wu H. The role of MICAL2 in cancer progression: mechanisms, challenges, and therapeutic potential. Hum Cell. 2025;38:89.","journal-title":"Hum Cell"},{"key":"9029_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41388-021-02101-z","volume":"41","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu R, Wang Y, Wang Y, Shuai Y, Ke C, et al. Phosphorylation of MICAL2 by ARG promotes head and neck cancer tumorigenesis by regulating skeletal rearrangement. Oncogene. 2022;41:334\u201346.","journal-title":"Oncogene"},{"key":"9029_CR28","doi-asserted-by":"publisher","first-page":"735180","DOI":"10.3389\/fonc.2021.735180","volume":"11","author":"B Pu","year":"2021","unstructured":"Pu B, Zhang X, Yan T, Li Y, Liu B, Jian Z, et al. MICAL2 Promotes Proliferation and Migration of Glioblastoma Cells Through TGF-\u03b2\/p-Smad2\/EMT-Like Signaling Pathway. Front Oncol. 2021;11:735180.","journal-title":"Front Oncol"},{"key":"9029_CR29","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.bbadis.2019.04.008","volume":"1865","author":"I Barravecchia","year":"2019","unstructured":"Barravecchia I, Mariotti S, Pucci A, Scebba F, De Cesari C, Bicciato S, et al. MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response. Biochim Biophys Acta - Mol Basis Dis. 2019;1865:2111\u201324.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"9029_CR30","doi-asserted-by":"publisher","first-page":"701354","DOI":"10.3389\/fphys.2021.701354","volume":"12","author":"E Pozzo","year":"2021","unstructured":"Pozzo E, Giarratana N, Sassi G, Elmastas M, Killian T, Wang C-C, et al. Upregulation of miR181a\/miR212 Improves Myogenic Commitment in Murine Fusion-Negative Rhabdomyosarcoma. Front Physiol. 2021;12:701354.","journal-title":"Front Physiol"},{"key":"9029_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1369\/0022155414561498","volume":"63","author":"H Yoon","year":"2015","unstructured":"Yoon H, Dehart JP, Murphy JM, Lim STS. Understanding the Roles of FAK in Cancer: Inhibitors, Genetic Models, and New Insights. J Histochem Cytochem. 2015;63:114.","journal-title":"J Histochem Cytochem"},{"key":"9029_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1083\/jcb.201307067","volume":"204","author":"C Jean","year":"2014","unstructured":"Jean C, Chen XL, Nam J-O, Tancioni I, Uryu S, Lawson C, et al. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function. J Cell Biol. 2014;204:247\u201363.","journal-title":"J Cell Biol"},{"key":"9029_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-0716-3036-5_8","volume":"2640","author":"N Giarratana","year":"2023","unstructured":"Giarratana N, Conti F, Rinvenuti L, Ronzoni F, Sampaolesi M. State of the Art Procedures for the Isolation and Characterization of Mesoangioblasts. Methods Mol Biol Clifton NJ. 2023;2640:99\u2013115.","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"9029_CR34","first-page":"18","volume":"92","author":"AG Lashen","year":"2025","unstructured":"Lashen AG, Toss MS, Rutland CS, Green AR, Mongan NP, Rakha E. Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast Cancer. Pathobiology. 2025;92:18\u201327.","journal-title":"Pathobiology"},{"key":"9029_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.humpath.2016.07.013","volume":"57","author":"B Choy","year":"2016","unstructured":"Choy B, LaLonde A, Que J, Wu T, Zhou Z. MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions. Hum Pathol. 2016;57:126\u201335.","journal-title":"Hum Pathol"},{"key":"9029_CR36","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1038\/sj.onc.1209435","volume":"25","author":"KA Honeycutt","year":"2006","unstructured":"Honeycutt KA, Chen Z, Koster MI, Miers M, Nuchtern J, Hicks J, et al. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Oncogene. 2006;25:4027\u201332.","journal-title":"Oncogene"},{"key":"9029_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.352","volume":"8","author":"K Qu","year":"2017","unstructured":"Qu K, Wang Z, Fan H, Li J, Liu J, Li P, et al. MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma. Cell Death Dis. 2017;8:e2603.","journal-title":"Cell Death Dis"},{"key":"9029_CR38","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.bbamcr.2013.07.013","volume":"1833","author":"P Mamczur","year":"2013","unstructured":"Mamczur P, Gamian A, Kolodziej J, Dziegiel P, Rakus D. Nuclear localization of aldolase A correlates with cell proliferation. Biochim Biophys Acta. 2013;1833:2812\u201322.","journal-title":"Biochim Biophys Acta"},{"key":"9029_CR39","doi-asserted-by":"publisher","first-page":"C1442","DOI":"10.1152\/ajpcell.00076.2010","volume":"300","author":"M Merkulova","year":"2011","unstructured":"Merkulova M, Hurtado-Lorenzo A, Hosokawa H, Zhuang Z, Brown D, Ausiello DA, et al. Aldolase directly interacts with ARNO and modulates cell morphology and acidic vesicle distribution. Am J Physiol Cell Physiol. 2011;300:C1442\u20131455.","journal-title":"Am J Physiol Cell Physiol"},{"key":"9029_CR40","doi-asserted-by":"publisher","first-page":"608474","DOI":"10.3389\/fphys.2020.608474","volume":"11","author":"AP Seabright","year":"2020","unstructured":"Seabright AP, Lai Y-C. Regulatory Roles of PINK1-Parkin and AMPK in Ubiquitin-Dependent Skeletal Muscle Mitophagy. Front Physiol. 2020;11:608474.","journal-title":"Front Physiol"},{"key":"9029_CR41","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3390\/cells12050716","volume":"12","author":"E Chatzinikita","year":"2023","unstructured":"Chatzinikita E, Maridaki M, Palikaras K, Koutsilieris M, Philippou A. The Role of Mitophagy in Skeletal Muscle Damage and Regeneration. Cells. 2023;12:716.","journal-title":"Cells"},{"key":"9029_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbapap.2016.09.019","volume":"1865","author":"Z Ostrowska","year":"2017","unstructured":"Ostrowska Z, Robaszkiewicz K, Moraczewska J. Regulation of actin filament turnover by cofilin-1 and cytoplasmic tropomyosin isoforms. Biochim Biophys Acta BBA - Proteins Proteomics. 2017;1865:88\u201398.","journal-title":"Biochim Biophys Acta BBA - Proteins Proteomics"},{"key":"9029_CR43","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cm.21586","volume":"77","author":"R Pinto-Costa","year":"2020","unstructured":"Pinto-Costa R, Sousa MM. Profilin as a dual regulator of actin and microtubule dynamics. Cytoskeleton. 2020;77:76\u201383.","journal-title":"Cytoskeleton"},{"key":"9029_CR44","doi-asserted-by":"publisher","unstructured":"Galloni C, Carra D, Abella JVG, Kj\u00e6r S, Singaravelu P, Barry DJ, et al. Mical2 enhances branched actin network disassembly by oxidizing arp3b-containing arp2\/3 complexes. J Cell Biol. 2021;220. https:\/\/doi.org\/10.1083\/jcb.202102043.","DOI":"10.1083\/jcb.202102043"},{"key":"9029_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/his.14449","volume":"80","author":"NP Agaram","year":"2022","unstructured":"Agaram NP. Evolving classification of rhabdomyosarcoma. Histopathology. 2022;80:98\u2013108.","journal-title":"Histopathology"},{"key":"9029_CR46","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.18632\/oncotarget.6577","volume":"7","author":"S Mariotti","year":"2016","unstructured":"Mariotti S, Barravecchia I, Vindigni C, Pucci A, Balsamo M, Libro R, et al. MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion. Oncotarget. 2016;7:1808\u201325.","journal-title":"Oncotarget"},{"key":"9029_CR47","first-page":"1997","volume":"19","author":"Y-J Guo","year":"2020","unstructured":"Guo Y-J, Pan W-W, Liu S-B, Shen Z-F, Xu Y, Hu L-L. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19:1997\u20132007.","journal-title":"Exp Ther Med"},{"key":"9029_CR48","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/cancers11101618","volume":"11","author":"C Braicu","year":"2019","unstructured":"Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, et al. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers. 2019;11:1618.","journal-title":"Cancers"},{"key":"9029_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41392-023-01329-3","volume":"8","author":"P Wang","year":"2023","unstructured":"Wang P, Jia X, Lu B, Huang H, Liu J, Liu X, et al. Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1\/2. Signal Transduct Target Ther. 2023;8:96.","journal-title":"Signal Transduct Target Ther"},{"key":"9029_CR50","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1002\/mc.23818","volume":"63","author":"D He","year":"2024","unstructured":"He D, Niu C, Bai R, Chen N, Cui J. ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK\/AKT Pathway in Colorectal Cancer. Mol Carcinog. 2024;63:2401\u201313.","journal-title":"Mol Carcinog"},{"key":"9029_CR51","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3748\/wjg.v21.i8.2323","volume":"21","author":"Y-J Cheng","year":"2015","unstructured":"Cheng Y-J, Zhu Z-X, Zhou J-S, Hu Z-Q, Zhang J-P, Cai Q-P, et al. Silencing profilin-1 inhibits gastric cancer progression via integrin \u03b21\/focal adhesion kinase pathway modulation. World J Gastroenterol. 2015;21:2323\u201335.","journal-title":"World J Gastroenterol"},{"key":"9029_CR52","doi-asserted-by":"publisher","first-page":"9343","DOI":"10.3390\/ijms24119343","volume":"24","author":"D Delgado-Bellido","year":"2023","unstructured":"Delgado-Bellido D, Oliver FJ, Vargas Padilla MV, Lobo-Selma L, Chac\u00f3n-Barrado A, D\u00edaz-Martin J, et al. VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation. Int J Mol Sci. 2023;24:9343.","journal-title":"Int J Mol Sci"},{"key":"9029_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05666-7","volume":"14","author":"D Delgado-Bellido","year":"2023","unstructured":"Delgado-Bellido D, Zamudio-Mart\u00ednez E, Fern\u00e1ndez-Cort\u00e9s M, Herrera-Campos AB, Olmedo-Pelayo J, Perez CJ, et al. VE-Cadherin modulates \u03b2-catenin\/TCF-4 to enhance Vasculogenic Mimicry. Cell Death Dis. 2023;14:135.","journal-title":"Cell Death Dis"},{"key":"9029_CR54","doi-asserted-by":"publisher","first-page":"31906","DOI":"10.1074\/jbc.M505568200","volume":"280","author":"MD Potter","year":"2005","unstructured":"Potter MD, Barbero S, Cheresh DA. Tyrosine Phosphorylation of VE-cadherin Prevents Binding of p120- and \u03b2-Catenin and Maintains the Cellular Mesenchymal State. J Biol Chem. 2005;280:31906\u201312.","journal-title":"J Biol Chem"},{"key":"9029_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.7150\/jca.22355","volume":"9","author":"Y Cai","year":"2018","unstructured":"Cai Y, Lu J, Tang F. Overexpression of MICAL2, a novel tumor-promoting factor, accelerates tumor progression through regulating cell proliferation and EMT. J Cancer. 2018;9:521\u20137.","journal-title":"J Cancer"},{"key":"9029_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02396-8","volume":"21","author":"HE Marei","year":"2021","unstructured":"Marei HE, Althani A, Afifi N, Hasan A, Caceci T, Pozzoli G, et al. p53 signaling in cancer progression and therapy. Cancer Cell Int. 2021;21:703.","journal-title":"Cancer Cell Int"},{"key":"9029_CR57","doi-asserted-by":"publisher","unstructured":"Pozzo E, Yedigaryan L, Giarratana N, Wang C, Garrido GM, Degreef E, et al. miR-449a\/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma. Cell Rep. 2025;44. https:\/\/doi.org\/10.1016\/j.celrep.2024.115171.","DOI":"10.1016\/j.celrep.2024.115171"},{"key":"9029_CR58","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1158\/0008-5472.CAN-24-0744","volume":"85","author":"B Garg","year":"2025","unstructured":"Garg B, Khan S, Courelli AS, Panneerpandian P, Sheik Pran Babu D, Mose ES, et al. MICAL2 Promotes Pancreatic Cancer Growth and Metastasis. Cancer Res. 2025;85:1049\u201363.","journal-title":"Cancer Res"},{"key":"9029_CR59","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3390\/ijms22041939","volume":"22","author":"FL Ronzoni","year":"2021","unstructured":"Ronzoni FL, Giarratana N, Crippa S, Quattrocelli M, Cassano M, Ceccarelli G, et al. Guide Cells Support Muscle Regeneration and Affect Neuro-Muscular Junction Organization. Int J Mol Sci. 2021;22:1939.","journal-title":"Int J Mol Sci"},{"key":"9029_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03936-w","volume":"12","author":"N Breuls","year":"2021","unstructured":"Breuls N, Giarratana N, Yedigaryan L, Garrido GM, Carai P, Heymans S, et al. Valproic acid stimulates myogenesis in pluripotent stem cell-derived mesodermal progenitors in a NOTCH-dependent manner. Cell Death Dis. 2021;12:677.","journal-title":"Cell Death Dis"},{"key":"9029_CR61","doi-asserted-by":"publisher","first-page":"977617","DOI":"10.3389\/fimmu.2022.977617","volume":"13","author":"L Yedigaryan","year":"2022","unstructured":"Yedigaryan L, Mart\u00ednez-Sarr\u00e0 E, Giacomazzi G, Giarratana N, van der Veer BK, Rotini A, et al. Extracellular vesicle-derived miRNAs improve stem cell-based therapeutic approaches in muscle wasting conditions. Front Immunol. 2022;13:977617.","journal-title":"Front Immunol"},{"key":"9029_CR62","first-page":"120","volume":"18","author":"C Cawthorne","year":"2007","unstructured":"Cawthorne C, Swindell R, Stratford IJ, Dive C, Welman A. Comparison of Doxycycline Delivery Methods for Tet-Inducible Gene Expression in a Subcutaneous Xenograft Model. J Biomol Tech JBT. 2007;18:120\u20133.","journal-title":"J Biomol Tech JBT"},{"key":"9029_CR63","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinforma Oxf Engl. 2014;30:2114\u201320.","journal-title":"Bioinforma Oxf Engl"},{"key":"9029_CR64","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907\u201315.","journal-title":"Nat Biotechnol"},{"key":"9029_CR65","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao Y, Smyth GK, Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 2013;41:e108.","journal-title":"Nucleic Acids Res"},{"key":"9029_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"9029_CR67","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41587-021-00860-4","volume":"39","author":"CB Messner","year":"2021","unstructured":"Messner CB, Demichev V, Bloomfield N, Yu JSL, White M, Kreidl M, et al. Ultra-fast proteomics with Scanning SWATH. Nat Biotechnol. 2021;39:846\u201354.","journal-title":"Nat Biotechnol"},{"key":"9029_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods. 2020;17:41\u201344.","journal-title":"Nat Methods"},{"key":"9029_CR69","doi-asserted-by":"crossref","unstructured":"Kistner F, Grossmann JL, Sinn LR, Demichev V. QuantUMS: uncertainty minimisation enables confident quantification in proteomics. bioRxiv 2023; 2023.06.20.545604.","DOI":"10.1101\/2023.06.20.545604"},{"key":"9029_CR70","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09029-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09029-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09029-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:11:53Z","timestamp":1790741513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09029-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9029"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09029-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All experimental procedures were performed in accordance with the relevant guidelines and regulations. The Institutional Animal Care and Research Advisory Committee of KU Leuven have provided approval for all relevant housing and experimental animal procedures (ECD #P089\/2018).","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"845"}}